TriSalus Life Sciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $20.4M | $8.5M | $11.8M | $9.4M | $200.9K | $1.3M |
| Accounts Receivable | $6.6M | $5.1M | $3.6M | $1.6M | — | — |
| Inventory | $3.1M | $4.0M | $2.5M | $1.5M | — | — |
| Total Current Assets | $32.2M | $20.7M | $20.9M | $17.2M | $525.9K | $2.0M |
| Property, Plant & Equipment | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $0 | $802.0K | — | — |
| Total Assets | $35.3M | $24.0M | $24.6M | $22.0M | $250.5M | $252.0M |
| Liabilities | ||||||
| Accounts Payable | $3.0M | $2.3M | $3.4M | $4.9M | — | — |
| Total Current Liabilities | $11.5M | $10.2M | $14.7M | $32.4M | $1.6M | — |
| Long-Term Debt | $33.0M | $22.1M | $0 | — | — | — |
| Total Liabilities | $69.2M | $49.9M | $51.7M | $34.3M | $17.3M | $23.5M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-330.6M | $-279.5M | $-249.5M | $-186.4M | $-16.7M | $-21.5M |
| Total Stockholders' Equity | $-33.9M | $-25.9M | $-27.1M | $-177.1M | $-129.6M | $-21.5M |